Postdoctoral position in Biopharmaceuticals (AAV gene therapy for neurodegenerative disease)
Uppsala University, Department of Pharmacy
All verified opportunities · More from Uppsala University
Who can apply: A PhD in a relevant field such as molecular biology, biotechnology, gene therapy or neuroscience, obtained by the time of the employment decision. Priority goes to applicants whose degree is no more than three years old at the application deadline, with extensions for sick leave, parental leave and similar…. What is funded: A full-time, two-year temporary postdoc employment at the Department of Pharmacy in Uppsala, starting 1 February 2027 or as agreed. Salary is set individually, and the advert prints no figure. There is no cover letter: applicants answer set questions in the university’s recruitment system instead. Deadline: 16 November 2026. No closing time or time zone is printed.
Read the full call and apply on the official page: Uppsala University, Department of Pharmacy, official page.
Who can apply
- A PhD in a relevant field such as molecular biology, biotechnology, gene therapy or neuroscience, obtained by the time of the employment decision. Priority goes to applicants whose degree is no more than three years old at the application deadline, with extensions for sick leave, parental leave and similar. Experimental experience in molecular biology, gene therapy or biologics is required, and the candidate must be willing to work with animal experiments. The position may be subject to security vetting. The advert invites applicants who are considering moving to Sweden.
Stage dates
Apply through Uppsala University's recruitment system (reference UFV-PA 2026/3107), answering the application questions that replace the cover letter.16 November 2026
Starting date 1 February 2027 or as agreed.1 February 2027
Dates come from the funder's page for this round. When a round closes, the next round's dates replace these once the funder publishes them.